Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goldenberg

Showing results (311-320 of 380) with videos related to

Pageof 38
Sort By:
Blood|November 24, 2025
Multisite Validation of a Venous Thrombosis Risk Model in Critically Ill Children Through the CHAT ConsortiumJulie Jaffray, Brian R Branchford, Maua Mosha Alleyne, et al.
Seminars in Thrombosis and Hemostasis|September 19, 2024
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT TrialHope P Wilson, Maua Mosha, Alexandra Miller, et al.
Blood Advances|September 25, 2024
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trialMarisol Betensky, Maua Mosha, Cristina Tarango, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world dataAmy L Kiskaddon, Nhue L Do, Ernest K Amankwah, et al.
Thrombosis and Haemostasis|June 28, 2016
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillationJohn M Kittelson, Philippe Gabriel Steg, Jonathan L Halperin, et al.
Circulation|September 24, 2014
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart AssociationSusan R Kahn, Anthony J Comerota, Mary Cushman, et al.
JAMIA Open|September 3, 2024
Leveraging a global, federated, real-world data network to optimize investigator-initiated pediatric clinical trials: the TriNetX Pediatric Collaboratory NetworkJurran L Wilson, Marisol Betensky, Sharda Udassi, et al.
Thrombosis Research|February 28, 2024
Considerations for instituting pediatric pulmonary embolism response teams: A tool kitMadhvi Rajpurkar, Rachel P Rosovsky, Suzan Williams, et al.
Journal of Medical Genetics|March 8, 2003
The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiencyM Chol, S Lebon, P Bénit, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2023
Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortiumJulie Jaffray, Maua Mosha, Brian Branchford, et al.
Pageof 38

Showing results (311-320 of 380) with videos related to

Sort By:
Pageof 38
Blood|November 24, 2025
Multisite Validation of a Venous Thrombosis Risk Model in Critically Ill Children Through the CHAT ConsortiumJulie Jaffray, Brian R Branchford, Maua Mosha Alleyne, et al.
Seminars in Thrombosis and Hemostasis|September 19, 2024
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT TrialHope P Wilson, Maua Mosha, Alexandra Miller, et al.
Blood Advances|September 25, 2024
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trialMarisol Betensky, Maua Mosha, Cristina Tarango, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world dataAmy L Kiskaddon, Nhue L Do, Ernest K Amankwah, et al.
Thrombosis and Haemostasis|June 28, 2016
Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillationJohn M Kittelson, Philippe Gabriel Steg, Jonathan L Halperin, et al.
Circulation|September 24, 2014
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart AssociationSusan R Kahn, Anthony J Comerota, Mary Cushman, et al.
JAMIA Open|September 3, 2024
Leveraging a global, federated, real-world data network to optimize investigator-initiated pediatric clinical trials: the TriNetX Pediatric Collaboratory NetworkJurran L Wilson, Marisol Betensky, Sharda Udassi, et al.
Thrombosis Research|February 28, 2024
Considerations for instituting pediatric pulmonary embolism response teams: A tool kitMadhvi Rajpurkar, Rachel P Rosovsky, Suzan Williams, et al.
Journal of Medical Genetics|March 8, 2003
The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiencyM Chol, S Lebon, P Bénit, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2023
Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortiumJulie Jaffray, Maua Mosha, Brian Branchford, et al.
Pageof 38